UnknownNot Applicable

A Non-interventional, Observational Study for Quality of Life (Overall Health Assessment) in Patients With Chronic Severe Pain During Targinact® Treatment

Belgium1,800 participantsStarted 2012-09

Plain-language summary

This non-interventional, observational study evaluates the efficacy of Targinact with regard to quality of life in daily clinical practice in Belgium compared to the previous analgesic treatment.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: Patients enrolled in the study are patients who * are eligible for Targinact® treatment according to the Targinact® SPC AND * who have previously been treated with WHO step 1, 2 or 3 analgesics Exclusion criteria are based on the Targinact® SPC.

What they're measuring

Assess the efficacy of Targinact® treatment

Timeframe: 12 weeks

Trial details

NCT IDNCT01710917

SponsorMundipharma CVA

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2013-11

Contact for this trial

Maggie C Wilson

Info@contact-clinical-trials.com

View on ClinicalTrials.gov More Chronic Severe Pain trials